| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,615 |
3,875 |
$153K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,931 |
2,421 |
$122K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,100 |
920 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,024 |
485 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
983 |
856 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
88 |
79 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
66 |
64 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
18 |
18 |
$773.16 |
| 90688 |
|
127 |
113 |
$651.52 |
| 92552 |
|
28 |
28 |
$360.08 |
| 99173 |
|
46 |
44 |
$259.16 |
| 81003 |
|
122 |
110 |
$189.96 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
15 |
13 |
$94.13 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
56 |
52 |
$83.19 |
| 99497 |
|
14 |
13 |
$82.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
227 |
194 |
$82.74 |
| 81001 |
|
36 |
28 |
$66.32 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$39.96 |
| 96160 |
|
27 |
24 |
$31.43 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
16 |
13 |
$21.31 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
13 |
12 |
$2.90 |
| 1170F |
|
13 |
12 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
13 |
12 |
$0.00 |